4 research outputs found
μ½λ¬Όλμ¬μ²΄νμ μ΄μ©ν μ§μΈλ Έμ¬μ΄λ Rk1μ ννμν μμ© κΈ°μ κ΄λ ¨ λμ¬μ²΄ κ·λͺ
νμλ
Όλ¬Έ (λ°μ¬)-- μμΈλνκ΅ λνμ : μ½νκ³Ό, 2013. 2. κΆμ±μ.νμνμ νκ΄ μμ λ° μΆνμ΄ μκΈ°λ κ²½μ° νμ±ν λμ΄ μ§νμμ©μ μ€μν μν μ νλ μΈν¬λ‘μ, κ³Όλν μ§ν μμ©μ μν΄ μκΈ΄ νμ (thrombus)μΌλ‘λΆν° νμ‘ μν μ₯μ λ° μ¬κ·Ό κ²½μμ¦, λμ‘Έμ€ λ± λ€μν μ§νμ μ λ°νλ€. μ΅κ·Ό μ¬νκ΄μ§ν λ°λ³μ¨μ΄ μ¦κ°νκ³ μμΌλ©°, νμνμ μκ³ κΈ°μ μ μ΅μ μν€λ μ½λ¬Όμ κ°λ° λ° κΈ°μ μ°κ΅¬λ μ¬νκ΄κ³ μ§ν μΉλ£μ κ°λ°μ λ§€μ° μ μ©νλ€κ³ ν μ μλ€.
μ½λ¬Όλμ¬μ²΄ν(Pharmacometabolomics)μ μΈν¬, μ‘°μ§, νΉμ μμ²΄μ‘ μμ ν¬ν¨λμ΄ μλ μ λΆμλ λ¬Όμ§μΈ λμ¬μ²΄ (metabolite)λ₯Ό κ·Έ λμμΌλ‘ νλ λμ¬μ²΄ν μ€ νλλ‘μ, μ½λ¬Όμ μν΄ λ³νλ λ§μ λμ¬μ²΄λ₯Ό λμμ κ΄μ°°νκ³ , λμ¬μ²΄λ€ κ°μ κ΄κ³λ₯Ό μ€λͺ
νλ νλ¬Έμ΄λΌ ν μ μλ€. λμμ κ΄μ°°λλ λ§μ λμ¬μ²΄μ λ³νλ ν΅κ³μ κΈ°λ²μ μ΄μ©νμ¬ ν΄μν μ μμΌλ©°, λ³νλ λμ¬μ²΄λ₯Ό ν΅νμ¬ μ½λ¬ΌκΈ°μ μ°κ΅¬μ μ€μ©ν μ 보λ₯Ό μ 곡νκ³ , νλ³ λΆμ λͺ¨λΈλ§μ ν΅νμ¬ μ§λ³μνμ μμΈ‘ λλ μ½λ¬Ό λ°μμ μν μμΈ‘μ λν κ°λ₯μ±μ μ μνκ³ μλ€.
μ΄μ λ³Έ μ°κ΅¬μμλ, arachidonic acidμ μνμ¬ μ λλλ νμν μμ§μμ©μ λν μ§μΈλ
Έμ¬μ΄λ Rk1μ μμ©κΈ°μ μ°κ΅¬λ₯Ό μ½λ¬Όλμ¬μ²΄νμ ν΅ν΄ μννκ³ μ νμλ€. νμν λ΄μ metabolites profilingμ UPLC/Q-TOFλ₯Ό μ΄μ©νμ¬ μ€μνμμΌλ©°, μμ§λ λ°μ΄ν°λ Profile analysis softwareμ μν΄ λ²μΌν
(Bucketing) λμλ€. μ£Όμ±λΆλΆμ (Principal component analysis PCA) λ° νλ³ λΆμ (Partial least square discriminant analysis, PLS-DA)μ SIMCA-P (v 12.0)λ₯Ό μ΄μ©νμ¬ μνλμμΌλ©°, νλ³ λΆμμ ν΅ν΄ κ·Έλ£Ήκ°μ μ°¨μ΄λ₯Ό κ·λͺ
ν μ μλ λμ¬μ²΄λ₯Ό ν¨κ³Όμ μΌλ‘ νλ³ ν μ μμλ€. νμνμ΄ μμ§λ μνκ³Ό μ§μΈλ
Έμ¬μ΄λ Rk1μ΄ μ²λ¦¬λ μν κ΅°μμ 12(S)-Hydroxyeicosatetradecaenoic acid (12(S)-HETE) κ° μ μμ± μκ² κ°μλ κ²μ νμΈ ν μ μμμΌλ©°, μ΄λ positive controlλ‘ μ¬μ©νλ μμ€νΌλ¦° μ²λ¦¬κ΅° κ³Όλ ꡬλ³λλ λμ¬μ²΄μμ νμΈ νμλ€. λ°λ©΄, Thromboxane B2μ κ²½μ° μμ€νΌλ¦° μ²λ¦¬ κ΅°κ³Ό ꡬλ³λμ§ μμμ νμΈ ν μ μμλ€. μ΄μ, μ§μΈλ
Έμ¬μ΄λ Rk1μ ννμν μμ©μ TXB2μ μμ±μ μ΅μ νλ μμ€νΌλ¦°μ μμ©κΈ°μ μλ κ΄μ¬νλ©°, 12(S)-HETEμ μμ±κΈ°μ μ΄ ννμν μμ§μμ©μ κΈ°μ¬νλ κ²μΌλ‘ νμΈ νμλ€. λν, λ³Έ μ€νμμλ μ§μΈλ
Έμ¬μ΄λ Rk1μ΄ μΈν¬ λ΄ μΉΌμ μ 리 λ° μΈλΆλ‘λΆν°μ μΉΌμ μ μ
μ ν¨κ³Όμ μΌλ‘ μ΅μ νλ κ²μ νμΈνμλ€. μ΄μ, μΉΌμ λλλ³νμ 12-LOXμ μ°κ³μ±μ νμΈνμκ³ , 12-HETEμ μμ±μ μΉΌμμ λλλ³νκ° 12-LOXμ translocationμ μν₯μ λ―ΈμΉ¨μΌλ‘μ¨ λνλ΄λ νμμΌλ‘ νλ¨νμλ€.κ΅λ¬Έμ΄λ‘ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ i
λͺ©μ°¨ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ iii
List of Figures β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ vi
List of Tables β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ viii
List of Abbreviations β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ ix
β
. μ λ‘ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 1
1. μ½λ¬Όλμ¬μ²΄ν β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 1
1-1. μ½λ¬Όλμ¬μ²΄νμ μμ λ° λͺ©μ β¦β¦β¦β¦β¦β¦β¦β¦β¦ 1
1-2. μ£Όμ±λΆ λΆμ λ° νλ³ λΆμ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 3
2. νμνμ μ리 λ° νμ±ν β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 5
3. Ginsenoside Rk1μ ννμν μμ© β¦β¦β¦β¦β¦β¦β¦β¦β¦ 8
β
‘. μ€ ν λ°© λ² β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 11
1. μ€ν μ¬λ£, μμ½ λ° κΈ°κΈ° β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 11
1-1. μ¬λ£ λ° μμ½ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 11
1-2. μ€ν λλ¬Ό β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 11
1-3. μ€ν κΈ°κΈ°β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 12
2. Ginsenoside Rk1μ λΆλ¦¬ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 13
2-1. κ°κ³΅μΈμΌ (Sun ginseng, SG)μ μ μ‘° β¦β¦β¦β¦β¦β¦β¦ 13
2-2. Ginsenoside Rk1μ λΆλ¦¬ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 13
3. Ginsenoside Rk1μνμνμμ§μ΅μ νμ± β¦β¦β¦β¦β¦β¦ 14
3-1. Washed platelets (WP)μ μ μ‘° β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 14
3-2. νμνμμ§μ΅μ νμ± β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 14
4. UPLC/Q-TOF MS λΆμλ°©λ²μ κ²μ¦ β¦β¦β¦β¦β¦β¦β¦β¦ 17
4-1. λΆμ쑰건 β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 17
4-2. λΆμλ² κ²μ¦ (Method validation)β¦β¦β¦β¦β¦β¦β¦β¦β¦ 18
5. νμν λ΄μ λμ¬μ²΄ λΆμ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 19
5-1. λΆμ쑰건 β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 19
5-2. λΆμμν μ μ‘° β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 19
6. λ°μ΄ν° μμ§ λ° μ²λ¦¬ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 21
7. λ€λ³λ λΆμ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 22
8. Cyclooxygenase (COX) νμ±β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 23
8-1. COX νμ±μ κ²μ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 23
8-2. ν΅κ³μ μ²λ¦¬λ² β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 23
9. νμν λ΄ calcium λ³ν μΈ‘μ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 24
10. Western blot analysis β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 25
β
’. κ²°κ³Ό λ° κ³ μ°° β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 27
1. Ginsenoside Rk1μ ννμν μμ§μμ© β¦β¦β¦β¦β¦β¦β¦ 27
2. μμ€ν
λΆμλ¬Ό λΆμ λ° μ κ±°β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 28
3. UPLC/Q-TOFMS λΆμλ² κ²μ¦ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 30
4. UPLC/Q-TOFMSλ₯Ό μ΄μ©ν λμ¬μ²΄ λΆμ β¦β¦β¦β¦β¦β¦β¦ 34
5. μ£Όμ±λΆ λΆμ λ° νλ³λΆμ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 41
6. Eicosanoids λ° TXB2 μμ±μ΅μ ν¨κ³Ό β¦β¦β¦β¦β¦β¦β¦β¦ 46
7. Cyclooxygenase (COX) μ ν΄ νμ±β¦β¦β¦β¦β¦β¦β¦β¦β¦ 48
8. νμν λ΄ calcium λλ μΈ‘μ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 51
9. 12-Lipoxygenase (12-LOX)μ translocation β¦β¦β¦β¦ 53
β
₯. κ²° λ‘ β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 54
β
€. μ°Έ κ³ λ¬Έ ν β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 57
Abstract β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦β¦ 62Docto